BMO Capital Starts Mirati Therapeutics (MRTX) at Market Perform on Balanced Risk/Reward
Tweet Send to a Friend
BMO Capital analyst George Farmer initiates coverage on Mirati Therapeutics (NASDAQ: MRTX) with a Market Perform rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
